Florida Senate - 2019                        COMMITTEE AMENDMENT
       Bill No. PCS (712656) for CS for SB 1528
       
       
       
       
       
       
                                Ì534426*Î534426                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                 Comm: UNFAV           .                                
                  04/18/2019           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Appropriations (Powell) recommended the
       following:
       
    1         Senate Amendment to Amendment (858228) 
    2  
    3         Between lines 159 and 160
    4  insert:
    5         (b) The drug’s manufacturer has not had a report of an
    6  investigator’s observation or a safety violation identified by
    7  the United States Food and Drug Administration or an in-country
    8  inspector within the previous 5 years;